Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05053776
Other study ID # Respiratory morbidities in CP
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 1, 2021
Est. completion date January 1, 2023

Study information

Verified date September 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Relationship between respiratory morbidities and cerebral palsy in children


Description:

Identification of symptoms,signs,severity and outcomes of respiratory morbidities in children with Cp


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date January 1, 2023
Est. primary completion date October 1, 2022
Accepts healthy volunteers
Gender All
Age group 1 Month to 18 Years
Eligibility Inclusion Criteria: - children with CP from 1 month to 18 years Exclusion Criteria: - neonates with Cp CP patients more than 18 years old

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Remonda Ramsis Hennis

Outcome

Type Measure Description Time frame Safety issue
Primary Chest auscultation Identify any respiratory abnormalities in CP patients Baseline
Secondary Chest X-ray Identify any chest infection in CP patients Baseline
See also
  Status Clinical Trial Phase
Completed NCT02617771 - Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care. Phase 4
Terminated NCT04408443 - Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients N/A
Recruiting NCT05684848 - Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing N/A
Recruiting NCT06201494 - Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Completed NCT04322669 - Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) Phase 4